 BOSTON, Sept. 30, 2021 GLOBE NEWSWIRE -- Decibel Therapeutics Nasdaq: DBTX, a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that findings from a study of noise-related inner ear damage conducted in collaboration with the University of Maryland School of Medicine UMSOM and the Karolinska Institute KI have been published in Cell Reports . 